Last updated: January 23, 2026
Platform | Vendor-Neutral OEM Support | AI Alert Triage/CPT Automation | Key Pros/Cons |
#1 Rhythm360 | All major OEMs (Medtronic, Boston Scientific, Abbott, Biotronik) | AI-powered triage, 80% faster alerts, 300% revenue increase | Pros: Mobile app, bi-directional EHR, CardioMEMS support Cons: None mentioned in official documentation |
#2 Murj | Device-agnostic multi-OEM support | Workflow automation, basic billing | Pros: Cloud-based, workflow focus Cons: Limited AI capabilities |
#3 PaceMate | Vendor-neutral with expanding OEM coverage | Advanced AI Auto-Triage | Pros: Acquired PaceArt assets Cons: Legacy integration challenges |
#4 Implicity | Select OEM partnerships | AI filtering, limited automation | Pros: Strong AI focus Cons: Limited HF-specific features |
Rhythm360 leads the market with broad vendor-neutral support across all major device manufacturers. The platform’s AI-powered alert triage system processes data from pacemakers, ICDs, CRT devices, and CardioMEMS sensors. It delivers actionable insights while filtering non-critical notifications. Practices report 80% faster response times for critical events such as new-onset atrial fibrillation or device malfunctions.
The platform’s automated CPT code capture supports compliance with 93298, 93299, and 99454. This automation helps practices recover previously lost revenue. Bi-directional EHR integration with Epic and Cerner removes manual data entry, and the HIPAA-compliant mobile app enables on-call monitoring from any location.
Murj focuses on workflow automation but lacks the depth of AI capabilities and multi-OEM support that complex cardiology practices often need. PaceMate recently acquired Medtronic’s PaceArt platform, which expands its capabilities but still introduces integration challenges with legacy systems.
Schedule a Rhythm360 demo to see how vendor-neutral integration can transform your heart failure management workflow.
Data fragmentation across OEM portals creates dangerous gaps in patient monitoring. Practices that manage devices from multiple manufacturers often waste hours logging into separate systems for Medtronic CareLink, Boston Scientific Latitude, Abbott Merlin.net, and Biotronik Home Monitoring.
Rhythm360 removes these silos through comprehensive API integration, HL7 messaging, and computer vision technology that extracts data from PDFs when direct connections are unavailable. The platform achieves greater than 99.9% data transmissibility through redundant feeds and AI-powered gap filling. This reliability helps ensure that critical information does not fall through the cracks.
This unified approach allows practices to view complete patient profiles regardless of device manufacturer. It supports the integrated care model required for effective heart failure management across all four pillars of treatment.
Alert fatigue creates a serious safety risk in cardiology practices. Traditional systems generate overwhelming volumes of non-actionable notifications. Clinicians then risk missing genuinely critical events such as ventricular tachycardia, lead fractures, or significant weight gain that signals fluid retention.
Rhythm360’s AI-powered triage system analyzes alert patterns, patient history, and clinical context to prioritize truly urgent notifications. When a patient’s CardioMEMS sensor detects elevated pulmonary artery pressures on a Saturday morning, the system flags this as high priority. Clinicians can intervene quickly and often prevent hospitalization.
This intelligent filtering reduces response times by 80%. It also keeps clinicians focused on patients who need immediate care instead of sorting through hundreds of routine device checks.
Heart failure monitoring requires capabilities that extend beyond basic cardiac rhythm management. Implantable hemodynamic monitoring devices show superior outcomes compared to noninvasive RPM, and CardioMEMS sensors reduce hospitalizations by 28%.
Rhythm360 integrates CardioMEMS pulmonary artery pressure data with traditional CIED monitoring, weight scales, and blood pressure cuffs. This combination provides comprehensive heart failure surveillance. The multi-modal approach supports all four pillars of HF management by tracking medication adherence, device performance, and physiological parameters in a single platform.
The platform’s HF-specific algorithms recognize patterns such as gradual weight gain combined with increased pulmonary artery pressures. Clinicians can then adjust medications proactively before decompensation occurs.
Revenue leakage from missed CPT codes creates a significant financial drain for cardiology practices. New 2026 CPT codes 99445 (~$47) and 99470 (~$26) expand billing opportunities for shorter monitoring periods, while traditional codes 93298, 93299, and 99454 remain central for device management.
Rhythm360 automatically tracks billable activities, generates compliant documentation, and applies proper coding for all monitoring services. Practices report RPM revenue increases of up to 300% through higher capture rates and fewer claim denials.
Seamless EHR integration removes the manual data entry burden that consumes valuable clinical time. Rhythm360’s bi-directional connections with Epic, Cerner, and other major systems allow patient data to flow automatically between platforms. These connections also maintain audit trails for compliance.
The secure mobile application supports on-call coverage without tying clinicians to desktop workstations. Critical alerts reach providers immediately through smartphone notifications. Clinicians can respond rapidly, regardless of location.
Clinical-grade RPM devices include FDA-cleared Class II devices like cellular-enabled weight scales. These devices provide the reliability and accuracy required for reimbursement and patient safety. Consumer devices such as Apple Watch support general wellness but lack the clinical-grade precision and integration capabilities needed for heart failure management.
Clinical-grade wearables undergo FDA approvals and integrate with RPM platforms using AI for arrhythmia detection. These devices deliver validated performance standards that consumer devices cannot match. Professional platforms also provide billing compliance, EHR integration, and clinical workflow support that consumer solutions do not offer.
The four pillars of heart failure management include guideline-directed medical therapy (GDMT) with ACE inhibitors, beta-blockers, and diuretics. The second pillar is device therapy, including pacemakers, ICDs, and CRT devices. The third pillar covers lifestyle modifications such as diet, exercise, and medication adherence. The fourth pillar is remote patient monitoring using platforms that track physiological parameters and device function. Effective HF management requires integration across all four pillars rather than isolated interventions.
Rhythm360 leads CardioMEMS monitoring through vendor-neutral integration that combines pulmonary artery pressure data with comprehensive cardiac device management. The platform’s AI algorithms analyze CardioMEMS trends alongside weight, blood pressure, and device parameters to provide holistic heart failure surveillance. This integrated approach supports proactive medication adjustments and prevents hospitalizations more effectively than single-parameter monitoring systems.
Rhythm360 offers broad vendor-neutral support across all major OEMs, and PaceMate provides vendor-neutral integration across major manufacturers and EHRs. Rhythm360’s AI-powered alert triage reduces response times by 80% and includes specialized heart failure algorithms for CardioMEMS and multi-parameter monitoring. The platform also delivers more comprehensive mobile access and automated CPT billing. These capabilities create higher ROI for practices that manage complex HF populations.
Cardiology practices reduce alert fatigue by using AI-powered triage systems that analyze clinical context, patient history, and alert patterns to prioritize critical events. Effective platforms filter routine device checks and highlight actionable alerts such as new arrhythmias, device malfunctions, or significant physiological changes. Rhythm360’s intelligent filtering reduces non-actionable alerts by more than 80% while ensuring that critical events receive immediate attention. This approach improves patient safety and clinician satisfaction.
The new 2026 CPT codes include 99445 for remote monitoring of physiological parameters over 2 to 15 days, with reimbursement of about $47. Code 99470 covers treatment management services that require real-time communication, with reimbursement of about $26. These codes complement existing cardiac device codes 93298 and 93299, along with traditional RPM codes 99453 and 99454. The new codes support billing for shorter monitoring periods and smaller time increments, which expands revenue opportunities for heart failure and chronic disease management programs.
Rhythm360 delivers comprehensive vendor-neutral integration, AI-driven intelligence, and clinical workflow improvements that modern cardiology practices need. The platform’s proven ability to reduce response times by 80% and increase RPM revenue by 300% positions it as a strong choice for practices focused on better outcomes and financial performance.
Schedule a Rhythm360 demo today to see how the #1 heart failure management platform can transform your practice’s efficiency and patient care quality.
